Found 266 matching trials
Study of HIV-1 Rgp-160 Administered by Mucosal Routes in Healthy Volunteers
PHASE1It is probable that a mucosal approach is necessary for a prophylactic HIV ...
Efficacy Study of Dendritic Cell Vaccination in Patients With Acute Myeloid Leukemia in Remission
PHASE2The primary aim of this innovative immunotherapeutic study is to determine ...
Status
Active Not Recruiting
Immunity and Safety of Covid-19 Synthetic Minigene Vaccine
PHASE1In December 2019, viral pneumonia caused by a novel beta-coronavirus (Covid...
Location
Shenzhen Geno-immune Medical Institute
Vaccine Therapy in Treating Patients With Liver or Lung Metastases From Colorectal Cancer
PHASE2RATIONALE: Vaccines made from a gene-modified virus and a person's white bl...
Location
Lombardi Comprehensive Cancer Center at Georgetown University Medical Center
Autologous TriMix-DC Therapeutic Vaccine in Combination With Ipilimumab in Patients With Previously Treated Unresectable Stage III or IV Melanoma
PHASE2The CTLA-4 blocking monoclonal antibody ipilimumab (MDX-010, BMS-734016), h...
Dendritic Cell-Based Tumor Vaccine Adjuvant Immunotherapy of Human Glioblastoma Multiforme (WHO Grade IV Gliomas)
PHASE2Purposes:
The purpose of this phase-II clinical trial is to determine whet...
Location
China Medical University Hospital
Vaccination of Melanoma Patients With Dendritic Cells Loaded With Allogeneic Apoptotic-Necrotic Melanoma Cells
PHASE1Background: Sixteen melanoma patients (1 stage IIC, 8 stage III, and 7 stag...
Location
Instituto Médico Alexander Fleming
Autologous Dendritic Cells Pulsed With Autologous Apoptotic Tumor Cells Administered to Patients With Brain Tumors
PHASE1This study involves cancer research and the purpose is to assess the safety...
Location
Rockefeller University
DC Vaccine Combined With IL-2 and IFNα-2a in Treating Patients With mRCC
PHASE2RATIONALE: Vaccines made from a patient's dendritic cells and tumor cells m...
Location
Norris Cotton Cancer Center at Dartmouth - Hitchcock Medical Center
The Use of Dendritic Cell/Tumor Hybridomas as a Novel Tumor Vaccine in Patients With Advance Melanoma
PHASE1This study aims to determine if the vacccine can be used safely in patients...